Inclusion Criteria:  The inclusion criteria are: Aged between 40-70 years Men and women 18-70 years BMI between 25-35 kg/m2 (overweight and obese) Serum total cholesterol < 8.0 mmol/L (further testing is recommended for excessive hyperlipidemia [serum total cholesterol ≥ 8.0 mmol/L] according to the Standard for cardiovascular risk management of the Dutch general practitioners community [NHG]) Serum triacylglycerol < 4.5 mmol/L No current smoker No diabetic patients No familial hypercholesterolemia No abuse of drugs Not more than 4 alcoholic consumption per day with a maximum of 21 per week?? Stable body weight (weight gain or loss < 3 kg in the past three months) No use of medication known to treat blood pressure, lipid or glucose metabolism No use of an investigational product within another biomedical intervention trial within the previous 1-month No severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis No active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study No difficult venipuncture as evidenced during the screening visit Willing to comply to study protocol during study Informed consent signed  Exclusion Criteria:  The exclusion criteria are: Allergy or intolerance to potatoes, pasta or rice Serum total cholesterol ≥ 8.0 mmol/L Serum triacylglycerol ≥ 4.5 mmol/L Current smoker, or smoking cessation <12 months Diabetic patients Familial hypercholesterolemia Abuse of drugs More than 4 alcoholic consumptions per day or 21 per week Unstable body weight (weight gain or loss > 3 kg in the past three months) Use medication known to treat blood pressure, lipid or glucose metabolism Use of an investigational product within another biomedical intervention trial within the previous 1-month Severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident Not willing to give up being a blood donor from 8 weeks before the start of the study, during the study or for 4 weeks after completion of the study Not or difficult to venipuncture as evidenced during the screening visit Use of over-the-counter and prescribed medication or supplements, which may interfere with study measurements to be judged by the principal investigator; Use of oral antibiotics in 40 days or less prior to the start of the study; Blood donation in the past 3 months before the start of the study Not willing to comply to study protocol during study or sign informed consent